Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-24T14:56:25.782Z Has data issue: false hasContentIssue false
  • English
  • Français

The Duration of Undiagnosed Bipolar Disorder: Impact of Substance use Disorders co-morbidity

Published online by Cambridge University Press:  23 March 2020

S. Ben Mustapha ,
W. Homri ,
L. Jouini  and
R. Labbane
W. Homri
Affiliation:
Razi Hospital, service de psychiatrie C, Mannouba, Tunisia
L. Jouini
Affiliation:
Razi Hospital, service de psychiatrie C, Mannouba, Tunisia
R. Labbane
Affiliation:
Razi Hospital, service de psychiatrie C, Mannouba, Tunisia

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Aims

Study the impact of substance use disorders (SUD) co-morbidity on the duration of undiagnosed bipolar disorder (DUBP).

Methods

Case-control study during a period of six months from July 2015 to December 2015. One hundred euthymic patients with BD (type I, II or unspecified) were recruited in the department of psychiatry C Razi Hospital, during their follow-up. Two groups were individualized by the presence or not of a SUD co-morbidity. In our study DUBP was defined as the period between the first symptoms and the beginning of treatment by a mood stabilizer.

Results

The beginning of addictive behaviour preceded the installation of bipolar disease in 32% of cases. Installation of bipolar disorder preceded the installation of addictive behaviour in 12% of cases. The beginning of addictive behaviour was concomitant with the installation of bipolar disease in 6% of cases. The average DUBP in the full sample was 4.80 years with a standard deviation of 8.04 and extremes ranging from 0.08 to 37.5.

The average DUBP in patients with SUD co-morbidity was 5.91 years with a standard deviation of 8.16 and extremes ranging from 0.08 to 35, and 3.68 years with a standard deviation of 7.84 and extremes ranging from 0.08 to 37.5 in patients without SUD co-morbidity.

Conclusions

According to studies over two thirds of patients with bipolar disorder received misdiagnoses before diagnosis of BD, and among the factors involved can report the presence of SUD co-morbidity. Hence, we should detect BD among patients with SUD.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster walk: Co-morbidity/dual pathologies and guidelines/Guidance – part 1
Information
European Psychiatry , Volume 41 , Issue S1: Abstract of the 25th European Congress of Psychiatry , April 2017 , pp. S132
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.